57.2 ð åèçïŒé«åž«åè / PGY OSCEïŒ
57.2.0.1 ð Cram Sheet
57.2.0.1.1 ð¥ é« yield 10
- Albumin correct: + 0.8 Ã (4 - albumin)
- HyperCa 90% = 1° HPT (outpatient) + malignancy (inpatient)
- PTH-dependent vs PTH-suppressed workflow
- PTHrP = humoral hypercalcemia of malignancy (squamous, breast, renal)
- Granulomatous / lymphoma = 1,25-vit D mediated â steroid responsive
- HyperCa Mx: NS â calcitonin â bisphosphonate â denosumab
- Calcitonin tachyphylaxis 48 hr
- Chvostek + Trousseau = hypoCa
- Replace Mg first if hypoCa + hypoMg
- FHH = familial, low urine Ca, normal/high PTH, donât operate
57.2.0.2 â é« yield
57.2.0.2.1 Hypercalcemia DDx
PTH high/normal: - Primary HPT - Tertiary HPT (CKD) - FHH (CASR mutation, low UCa) - Lithium
PTH suppressed: - Malignancy (osteolytic, PTHrP, 1,25-D, MM) - Granulomatous (sarcoid, TB) - Vit D / A intoxication - Hyperthyroid - Adrenal insufficiency - Immobilization - Milk-alkali
57.2.0.2.2 Treatment Algorithm
| Severity | Tx |
|---|---|
| Mild < 12 | hydration + treat cause |
| 12-14 | IV NS + bisphosphonate + treat |
| > 14 / sx | IV NS + calcitonin + bisphosphonate + (steroid for granulomatous) ± dialysis |
57.2.0.2.3 Bisphosphonate
- Zoledronic acid 4 mg IV (preferred for malignancy)
- Pamidronate 60-90 mg IV
- Onset 24-48 hr, duration weeks
- Renal dose adjust
- Risk: ONJ, hypoCa, atypical fracture
57.2.0.2.4 Denosumab
- For CKD severe (BP contraindicated)
- 60-120 mg SC
- Severe hypoCa risk (replete first)
57.2.0.2.6 Hypocalcemia Causes
Mnemonic 7P: - Post-thyroid surgery / Pseudohypoparathyroid - PTH (low) - hypoparathyroidism - Pancreatitis - Phosphate (hyperPO4 in CKD/TLS) - Plasma alkalosis - Mg low (functional) - Vit D Phototoxicity / def
57.2.0.3 ð¯ èªææª¢æž¬
- HyperCa outpatient most common? â 1° HPT
- HyperCa inpatient most common? â Malignancy
- PTHrP source? â Squamous, breast, renal
- FHH urine Ca? â Low
- Calcitonin tachyphylaxis? â 48 hr
- Granulomatous hyperCa Tx? â Steroid
- HypoCa + hypoMg? â Replace Mg first
- Chvostek + Trousseau? â HypoCa
- Albumin correct formula? â + 0.8 Ã (4 - alb)
- Denosumab side effect? â Severe hypoCa, ONJ
â ïž AI èçš¿ã